CEFOXITIN SODIUM (se-fox'i-tin) Mefoxin Classifications: antiinfective; antibiotic; second-generation cephalosporin Prototype: Cefonicid sodium Pregnancy Category: B |
1 g, 2 g injection
Semisynthetic, broad-spectrum beta-lactam antibiotic derivative of cephamycin C (produced by Streptomyces lactamdurans). Classified as second generation cephalosporin; structurally and pharmacologically related to cephalosporins and penicillins. Antimicrobial spectrum of activity resembles that of cefonicid. Considerably less active than most cephalosporins against Staphylococci. Preferentially binds to one or more of the penicillin-binding proteins (PBP) located on cell walls of susceptible organisms.
It shows enhanced activity against a wide variety of gram-negative organisms and is effective for mixed aerobic-anaerobic infections. Effectively treats gynecologic, bone and joint and intra-abdominal infections, gonorrhea, skin and urinary tract infections, and is used for surgical prophylaxis, reducing or eliminating infection.
Infections caused by susceptible organisms in the lower respiratory tract, urinary tract, skin and skin structures, bones and joints; also intra-abdominal endocarditis, gynecological infections, septicemia, uncomplicated gonorrhea, and perioperative prophylaxis in prosthetic arthroplasty or cardiovascular surgery. May be cephalosporin of choice for mixed aerobic-anaerobic infections (e.g., Bacteroides fragilis).
Hypersensitivity to cephalosporins and related antibiotics; pregnancy (category B), lactation. Safe use in children <3 mo not established.
History of sensitivity to penicillin or other allergies, particularly to drugs; impaired renal function.
Moderate to Severe Infections Adult: IV/IM 12 g q68h, up to 12 g/d Child >3 mo : IV/IM 80160 mg/kg/d in 46 divided doses (max: 12 g/d) Neonate: IV/IM 90100 mg/kg/d divided q8h Surgical Prophylaxis Adult: IV/IM 2 g 3060 min before surgery, then 2 g q6h for 24 h Child: IV/IM 3040 mg/kg 3060 min before surgery, then 2 g q6h for 24 h Uncomplicated Gonorrhea Adult: IV/IM 2 g given concurrently with 1 g probenecid PO |
Intravenous
PREPARE: Direct: Dilute each 1 g with 10 mL sterile water, D5W, or NS. Intermittent: Following reconstitution, dilute 12 g in 50100 mL of D5W or NS. ADMINISTER: Direct: Give over 35 min. Intermittent: Give over 15 min. INCOMPATIBILITIES Solution/additive: aminoglycosides, ranitidine. Y-site: aminoglycosides, filgrastim, hetastarch, pentamidine, vancomycin.
|
Cefoxitin causes false-positive (black-brown or green-brown color) urine glucose reaction with copper reduction reagents such as Benedict's or Clinitest, but not with enzymatic glucose oxidase reagents (Clinistix, TesTape). With high doses, falsely elevated serum and urine creatinine (with Jaffee reaction) reported. False-positive direct Coombs' test (may interfere with cross-matching procedures and hematologic studies) has also been reported.
Assessment & Drug Effects
Patient & Family Education